IKT
#3192
Inhibikase Therapeutics, Inc. - Common Stock
2.4 6 USD
+0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+3.36%
Changement Mensuel
+12.33%
Evolution sur 6 mois
+28.80%
Changement Annuel
+40.57%
Clôture Précédente
2.3 8
Open
2.3 9
Low
2.3 9
High
2.4 9
Volume
33
Financials
- Market Capitalization 343.26 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.61
ratio cours/chiffre d'affaires
54.94
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3185 |  IRD Opus Genetics, Inc. - Common Stock | 4.15 USD | +8.36% | +2.72% | +11.56% | +11.56% | 345.26 M USD | ||
| 3186 |  PALI Palisade Bio, Inc. - Common Stock | 1.98 USD | +1.02% | -3.88% | +4.21% | +16.47% | 345.06 M USD | ||
| 3196 |  STRO Sutro Biopharma, Inc. - Common Stock | 20.57 USD | -1.20% | -2.79% | -14.18% | +18.29% | 341.07 M USD | ||
| 3205 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.71 USD | +0.27% | -1.33% | +3.34% | +70.97% | 337.56 M USD |